AKTER JESMIN ＡＫＴＥＲＪＥＳＭＩＮ

Researcher Number	70795830
Affiliation (Current)	2025: 地方独立行政法人埼玉県立病院機構埼玉県立がんセンター(臨床腫瘍研究所), 臨床腫瘍研究所, 研究員
Affiliation (based on the past Project Information) *help	2024: 地方独立行政法人埼玉県立病院機構埼玉県立がんセンター(臨床腫瘍研究所), 臨床腫瘍研究所, 研究員 2021: 地方独立行政法人埼玉県立病院機構埼玉県立がんセンター(臨床腫瘍研究所), 臨床腫瘍研究所, 技師 2018 – 2020: 埼玉県立がんセンター(臨床腫瘍研究所), 臨床腫瘍研究所, 技師
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 50010:Tumor biology-related
Keywords	Principal Investigator ALT / Neuroblastoma / ATM / Chemoresistance / Telomere maintenance / Telomerase / ATM/Chk2/p53 / p53 / G-quadruplex / Replication stress … More / FANCD2 / TP53 / ATRX / 神経芽腫 Less

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastomaPrincipal Investigator
- Principal Investigator
  
  AKTER JESMIN
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Research Institute for Clinical Oncology Saitama Cancer Center
Study of ATRX mediated telomere maintenance in neuroblastoma by using genome editing technology (CRISPR/Cas9)Principal Investigator
- Principal Investigator
  
  AKTER JESMIN
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Research Institute for Clinical Oncology Saitama Cancer Center

All 2021 2020 2019 2018

All Journal Article Presentation

[Journal Article] How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?2021
- Author(s)
  Akter Jesmin、Kamijo Takehiko
- Journal Title
  
  Biomolecules
  
  Volume: 11 Issue: 8 Pages: 1112-1112
- DOI
  10.3390/biom11081112
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K15256, KAKENHI-PROJECT-19H03625
[Journal Article] NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers2021
- Author(s)
  Takatori Atsushi、Hossain MD. Shamim、Ogura Atsushi、Akter Jesmin、Nakamura Yohko、Nakagawara Akira
- Journal Title
  
  Frontiers in Oncology
  
  Volume: 11 Pages: 669667-669667
- DOI
  10.3389/fonc.2021.669667
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K15256
[Journal Article] Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma2021
- Author(s)
  Akter Jesmin、Katai Yutaka、Sultana Parvin、Takenobu Hisanori、Haruta Masayuki、Sugino Ryuichi P.、Mukae Kyosuke、Satoh Shunpei、Wada Tomoko、Ohira Miki、Ando Kiyohiro、Kamijo Takehiko
- Journal Title
  
  Oncogenesis
  
  Volume: 10 Issue: 11 Pages: 1256-1256
- DOI
  10.1038/s41389-021-00363-6
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K15256, KAKENHI-PROJECT-19K16759, KAKENHI-PROJECT-20K07579, KAKENHI-PROJECT-20K08174, KAKENHI-PROJECT-20K08269, KAKENHI-PROJECT-19H03625
[Journal Article] Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells.2019
- Author(s)
  Islam MS, Takano R, Yokochi T, Akter J, Nakamura Y, Nakagawara A, Tatsumi Y.
- Journal Title
  
  BMC Cancer.
  
  Volume: 19 Issue: 1 Pages: 542-542
- DOI
  10.1186/s12885-019-5772-4
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08665, KAKENHI-PROJECT-17K10132, KAKENHI-PROJECT-18K15256
[Journal Article] EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications2018
- Author(s)
  Li Zhenghao、Takenobu Hisanori、Setyawati Amallia Nuggetsiana、Akita Nobuhiro、Haruta Masayuki、Satoh Shunpei、Shinno Yoshitaka、Chikaraishi Koji、Mukae Kyosuke、Akter Jesmin、Sugino Ryuichi P.、Nakazawa Atsuko、Nakagawara Akira、Aburatani Hiroyuki、Ohira Miki、Kamijo Takehiko
- Journal Title
  
  Oncogene
  
  Volume: 37 Issue: 20 Pages: 2714-2727
- DOI
  10.1038/s41388-018-0133-3
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K10131, KAKENHI-PROJECT-18K15256, KAKENHI-PROJECT-17H01592, KAKENHI-PROJECT-16K10051, KAKENHI-PROJECT-17K19623
[Presentation] p53 deficiency limits ATRX loss induced replication stress and genome instability in neuroblastoma cells2020
- Author(s)
  AKTER JESMIN
- Organizer
  The 79th annual meeting of the Japanese Cancer Association
- Data Source
  KAKENHI-PROJECT-18K15256
[Presentation] ATM/CHK2/P53 PATHWAY INACTIVATION IS REQUIRED FOR ATRX-MUTATION-RELATED TUMORIGENESIS2018
- Author(s)
  AKTER JESMIN
- Organizer
  50th Congress of the International society of Pediatric Oncology (SIOP)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K15256
[Presentation] Genetic inactivation of ATRX can induces ATM dependent DNA damage response in neuroblastoma (NB) cells2018
- Author(s)
  AKTER JESMIN
- Organizer
  The 77th annual meeting of the Japanese Cancer Association
- Data Source
  KAKENHI-PROJECT-18K15256

1. TATSUMI Yasutoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. 市川美紀

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 中村洋子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

AKTER JESMIN ＡＫＴＥＲ ＪＥＳＭＩＮ

Research Projects

Research Products

Co-Researchers

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Study of ATRX mediated telomere maintenance in neuroblastoma by using genome editing technology (CRISPR/Cas9)Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications2018

Author(s)

Journal Title

DOI

Data Source

[Presentation] p53 deficiency limits ATRX loss induced replication stress and genome instability in neuroblastoma cells2020

Author(s)

Organizer

Data Source

[Presentation] ATM/CHK2/P53 PATHWAY INACTIVATION IS REQUIRED FOR ATRX-MUTATION-RELATED TUMORIGENESIS2018

Author(s)

Organizer

Data Source

[Presentation] Genetic inactivation of ATRX can induces ATM dependent DNA damage response in neuroblastoma (NB) cells2018

Author(s)

Organizer

Data Source

AKTER JESMIN ＡＫＴＥＲＪＥＳＭＩＮ